11-17509546-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_153676.4(USH1C):c.1823C>G(p.Pro608Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000692 in 1,602,700 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P608S) has been classified as Likely benign.
Frequency
Consequence
NM_153676.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH1C | NM_153676.4 | c.1823C>G | p.Pro608Arg | missense_variant | 18/27 | ENST00000005226.12 | NP_710142.1 | |
USH1C | NM_005709.4 | c.1285-7566C>G | intron_variant | ENST00000318024.9 | NP_005700.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH1C | ENST00000005226.12 | c.1823C>G | p.Pro608Arg | missense_variant | 18/27 | 5 | NM_153676.4 | ENSP00000005226 | ||
USH1C | ENST00000318024.9 | c.1285-7566C>G | intron_variant | 1 | NM_005709.4 | ENSP00000317018 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000593 AC: 90AN: 151748Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.000486 AC: 117AN: 240790Hom.: 0 AF XY: 0.000444 AC XY: 58AN XY: 130508
GnomAD4 exome AF: 0.000702 AC: 1019AN: 1450952Hom.: 1 Cov.: 38 AF XY: 0.000659 AC XY: 475AN XY: 720514
GnomAD4 genome AF: 0.000593 AC: 90AN: 151748Hom.: 0 Cov.: 28 AF XY: 0.000500 AC XY: 37AN XY: 74062
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 11, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 25, 2018 | The p.Pro608Arg variant (rs41282932) has been identified in a homozygous state in a single induvial with non-syndromic hearing loss (Ouyang 2002). However it has been identified in several other cases with an alternate molecular basis for hearing loss, suggesting that it is not a causative variant (Cremers 2007, and Vona 2014). The p.Pro608Arg variant has also been reported to ClinVar (Variation ID: 5148). This variant is listed in the NHLBI GO Exome Sequencing Project with an overall population frequency of 0.06 percent (identified on 8 out of 12,984 chromosomes) and is listed in the Genome Aggregation Database (gnomAD) with an overall population frequency of 0.05 percent (identified on 124 out of 267,276 chromosomes). The proline at position 608 is weakly conserved (considering 12 species) (Alamut v.2.8.1) and computational analyses of the effects of the p.Pro608Arg variant on protein structure and function provide conflicting results (SIFT: tolerated, MutationTaster: disease causing, PolyPhen-2: possibly damaging). Altogether, there is not enough evidence to classify the p.Pro608Arg variant with certainty. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 24, 2021 | Observed as a heterozygous variant in patients with hearing loss who harbored variants in other hearing loss-related genes (Cremers FP et al., 2007; Vona B et al., 2014; Nonose RW et al., 2018; Roman-Naranjo P et al., 2021); In silico analysis supports that this variant does not alter splicing; This variant is associated with the following publications: (PMID: 16963483, 12136232, 34391192, 30245029, 29739340, 24875298) - |
Usher syndrome type 1C Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Oct 08, 2021 | NM_005709.3(USH1C):c.1285-7566C>G is an intronic variant classified as a variant of uncertain significance in the context of USH1C-related disorders. c.1285-7566C>G has been observed in cases with relevant disease (PMID: 12136232, 29739340, 16963483, 24875298). Functional assessments of this variant are not available in the literature. c.1285-7566C>G has been observed in population frequency databases (gnomAD: NFE 0.08%). In summary, there is insufficient evidence to classify NM_005709.3(USH1C):c.1285-7566C>G as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 11, 2020 | - - |
Autosomal recessive nonsyndromic hearing loss 18A Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2002 | - - |
Meniere disease Uncertain:1
Uncertain significance, criteria provided, single submitter | case-control | Otology & Neurotology- Genomics of vestibular disorders (CTS-495), Jose Antonio López Escámez, Centro Pfizer - Universidad de Granada - Junta de Andalucía de Genómica e Investigación Oncológica (GENYO) | Jun 21, 2021 | Digenic inheritance along with NM_000260.4:c.6247G>A(MYO7A) - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 06, 2015 | p.Pro608Arg in exon 18 of USH1C: This variant has been previously reported in 3 individuals with Usher syndrome or hearing loss and 2 individuals by our laborat ory; 3 of whom have another genetic etiology to explain their hearing loss (Crem ers 2007, Vera 2014, LMM unpublished data). This variant has also been identifie d in 0.1% (51/60306) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs41282932). In summary, the prese nce of this variant in 3 individuals with another etiology for hearing loss and its frequency in the general population suggest that it is likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at